We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$243M
AUM Growth
+$7.78M
Cap. Flow
-$1.09M
Cap. Flow %
-0.45%
Top 10 Hldgs %
44.44%
Holding
75
New
2
Increased
23
Reduced
37
Closed
4

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$1.75M
2
QCOM icon
Qualcomm
QCOM
+$702K
3
CVS icon
CVS Health
CVS
+$387K
4
HAIN icon
Hain Celestial
HAIN
+$311K
5
PG icon
Procter & Gamble
PG
+$275K

Sector Composition

Rank Sector Weight
1 Healthcare 24.95%
2 Technology 17.94%
3 Consumer Staples 13.78%
4 Industrials 10.25%
5 Consumer Discretionary 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
51
Microsoft
MSFT
$3.45T
$586K 0.24%
8,495
+166
+2% +$11.4K
XOM icon
52
ExxonMobil
XOM
$644B
$517K 0.21%
6,378
-250
-4% -$20.5K
CLB icon
53
Core Laboratories
CLB
$488M
$500K 0.21%
4,950
CVS icon
54
CVS Health
CVS
$133B
$430K 0.18%
5,375
-4,895
-48% -$387K
CSCO icon
55
Cisco
CSCO
$457B
$427K 0.18%
13,767
-767
-5% -$25K
BIIB icon
56
Biogen
BIIB
$30B
$396K 0.16%
1,460
-325
-18% -$85.9K
GPC icon
57
Genuine Parts
GPC
$17.1B
$386K 0.16%
4,155
-100
-2% -$9.19K
T icon
58
AT&T
T
$159B
$362K 0.15%
12,623
+220
+2% +$6.49K
ESRX
59
DELISTED
Express Scripts Holding Company
ESRX
$322K 0.13%
5,035
-1,700
-25% -$107K
ETN icon
60
Eaton
ETN
$161B
$312K 0.13%
4,006
+150
+4% +$11.4K
HON icon
61
Honeywell
HON
$77B
$294K 0.12%
2,446
+603
+33% +$71.1K
KHC icon
62
Kraft Heinz
KHC
$30.7B
$291K 0.12%
3,387
-1,500
-31% -$136K
STZ icon
63
Constellation Brands
STZ
$22.2B
$251K 0.1%
+1,295
New +$231K
IBM icon
64
IBM
IBM
$211B
$246K 0.1%
1,674
CMA
65
DELISTED
Comerica
CMA
$245K 0.1%
3,357
-1,800
-35% -$126K
EMR icon
66
Emerson Electric
EMR
$83.9B
$243K 0.1%
4,057
BMY icon
67
Bristol-Myers Squibb
BMY
$133B
$237K 0.1%
4,225
WFC icon
68
Wells Fargo
WFC
$261B
$208K 0.09%
3,775
ADI icon
69
Analog Devices
ADI
$179B
$206K 0.08%
2,638
-2,525
-49% -$201K
MRK icon
70
Merck
MRK
$322B
$200K 0.08%
3,280
-90
-3% -$5.48K
GCVRZ
71
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$4K ﹤0.01%
10,660
HAIN icon
72
Hain Celestial
HAIN
$45M
-8,405
Closed -$311K
MO icon
73
Altria Group
MO
$114B
-3,307
Closed -$235K
TGT icon
74
Target
TGT
$65.6B
-3,675
Closed -$202K
VZ icon
75
Verizon
VZ
$195B
-4,414
Closed -$216K

Similar funds

Dillon & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Dillon & Associates held 75 positions worth $243M, up 3.3% from $235M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Dillon & Associates's Q2 2017 filing shows 2 new, 23 increased, 37 reduced and 4 closed positions. Its largest new stake was Euronet Worldwide: 11,070 shares worth $963K. The largest sale was SLB Ltd, an estimated $1.75M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Staples.

  • Dillon & Associates's largest Q2 2017 buy was Euronet Worldwide: 11,070 shares worth $963K.
  • Dillon & Associates added most to JPMorgan Chase in Q2 2017, an estimated $537K increase.
  • Dillon & Associates's biggest Q2 2017 reduction was SLB Ltd, cutting an estimated $1.75M.
  • Dillon & Associates fully exited Hain Celestial in Q2 2017, selling an estimated $311K.
  • Dillon & Associates's ten largest holdings make up 44% of its $243M portfolio in Q2 2017.
  • Dillon & Associates opened 2 new positions and closed 4 in Q2 2017.
  • Dillon & Associates's portfolio value rose 3.3% quarter-over-quarter to $243M.

Based on Dillon & Associates's 13F filing for Q2 2017, filed 9 Aug 2017.